These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24280262)

  • 1. Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy.
    Guo S; Miao L; Wang Y; Huang L
    J Control Release; 2014 Jan; 174():137-42. PubMed ID: 24280262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-coated Cisplatin nanoparticles induce neighboring effect and exhibit enhanced anticancer efficacy.
    Guo S; Wang Y; Miao L; Xu Z; Lin CM; Zhang Y; Huang L
    ACS Nano; 2013 Nov; 7(11):9896-904. PubMed ID: 24083505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy.
    Guo S; Wang Y; Miao L; Xu Z; Lin CH; Huang L
    Biomaterials; 2014 Aug; 35(26):7647-53. PubMed ID: 24920436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Turning an antiviral into an anticancer drug: nanoparticle delivery of acyclovir monophosphate.
    Yao J; Zhang Y; Ramishetti S; Wang Y; Huang L
    J Control Release; 2013 Sep; 170(3):414-20. PubMed ID: 23791977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-drug delivery of regorafenib and cisplatin with amphiphilic copolymer nanoparticles: enhanced
    Zhou Z
    Drug Deliv; 2020 Dec; 27(1):1319-1328. PubMed ID: 32936009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation of Intravesical Cisplatin Nanoparticles for Non-Muscle-Invasive Bladder Cancer.
    Kates M; Date A; Yoshida T; Afzal U; Kanvinde P; Babu T; Sopko NA; Matsui H; Hahn NM; McConkey DJ; Baras A; Hanes J; Ensign L; Bivalacqua TJ
    Clin Cancer Res; 2017 Nov; 23(21):6592-6601. PubMed ID: 28808039
    [No Abstract]   [Full Text] [Related]  

  • 9. Cisplatin-loaded gelatin-poly(acrylic acid) nanoparticles: synthesis, antitumor efficiency in vivo and penetration in tumors.
    Ding D; Zhu Z; Liu Q; Wang J; Hu Y; Jiang X; Liu B
    Eur J Pharm Biopharm; 2011 Sep; 79(1):142-9. PubMed ID: 21272637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin.
    Tan S; Wang G
    Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coordination self-assembly of platinum-bisphosphonate polymer-metal complex nanoparticles for cisplatin delivery and effective cancer therapy.
    Huang Y; He Y; Huang Z; Jiang Y; Chu W; Sun X; Huang L; Zhao C
    Nanoscale; 2017 Jul; 9(28):10002-10019. PubMed ID: 28682411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
    Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
    Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
    [No Abstract]   [Full Text] [Related]  

  • 15. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity.
    Yang F; Li A; Liu H; Zhang H
    Drug Des Devel Ther; 2018; 12():3321-3333. PubMed ID: 30323564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
    Chiang CS; Tseng YH; Liao BJ; Chen SY
    Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy drug delivery from calcium phosphate nanoparticles.
    Cheng X; Kuhn L
    Int J Nanomedicine; 2007; 2(4):667-74. PubMed ID: 18203433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
    Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
    J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.